Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Discovery of novel hydroxamates as highly potent tumor necrosis factor-[alpha] converting enzyme inhibitors. Part II: Optimization of the S3′ pocket

Journal Article · · Bioorg. Med. Chem. Lett.
A series of cyclopropyl hydroxamic acids were prepared. Many of the compounds displayed picomolar affinity for the TACE enzyme while maintaining good to excellent selectivity profiles versus MMP-1, -2, -3, -7, -14, and ADAM-10. X-ray analysis of an inhibitor in the TACE active site indicated that the molecules bound to the enzyme in the S1{prime}-S3{prime} pocket.
Research Organization:
Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
Sponsoring Organization:
USDOE
OSTI ID:
1007158
Journal Information:
Bioorg. Med. Chem. Lett., Journal Name: Bioorg. Med. Chem. Lett. Journal Issue: (21) ; 11, 2008 Vol. 18; ISSN 0960-894X
Country of Publication:
United States
Language:
ENGLISH

Similar Records

The discovery of novel tartrate-based TNF-[alpha] converting enzyme (TACE) inhibitors
Journal Article · Fri Sep 17 00:00:00 EDT 2010 · Bioorg. Med. Chem. Lett. · OSTI ID:1002634

Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF–FVIIa inhibitors
Journal Article · Tue Jan 29 23:00:00 EST 2013 · Bioorganic & Medicinal Chemistry Letters · OSTI ID:1353261